|
ARHGAP17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92220999999382E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.576700E-03 |
| Normal-vs-Stage2 |
4.199900E-03 |
| Normal-vs-Stage3 |
5.977000E-04 |
| Normal-vs-Stage4 |
2.168600E-01 |
| Stage1-vs-Stage2 |
1.348810E-01 |
| Stage1-vs-Stage3 |
3.514100E-02 |
| Stage1-vs-Stage4 |
7.811200E-01 |
| Stage2-vs-Stage3 |
7.753400E-01 |
| Stage2-vs-Stage4 |
5.266000E-01 |
| Stage3-vs-Stage4 |
3.913600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.04050000000011E-05 |
| Normal-vs-AfricanAmerican |
1.572440E-02 |
| Normal-vs-Asian |
5.400600E-01 |
| Caucasian-vs-AfricanAmerican |
2.376000E-01 |
| Caucasian-vs-Asian |
9.186800E-01 |
| AfricanAmerican-vs-Asian |
9.039800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76318999999259E-05 |
| Normal-vs-Female |
2.603000E-03 |
| Male-vs-Female |
5.553400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.413640E-01 |
| Normal-vs-Extreme_Weight |
4.169100E-04 |
| Normal-vs-Obese |
6.217100E-04 |
| Normal-vs-Extreme_Obese |
3.369200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.533580E-01 |
| Normal_Weight-vs-Obese |
9.474400E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.350200E-01 |
| Extreme_Weight-vs-Obese |
5.045400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.544800E-01 |
| Obese-vs-Extreme_Obese |
4.484400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.959330E-03 |
| Normal-vs-Age(41-60Yrs) |
1.76158999999343E-05 |
| Normal-vs-Age(61-80Yrs) |
1.016510E-03 |
| Normal-vs-Age(81-100Yrs) |
5.003000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.515980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.510000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.707620E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.624620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.422000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.788600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.88389999991701E-07 |
| Normal-VS-Type2 PRCC |
7.048200E-01 |
| Normal-VS-KIRP CIMP |
3.18300000023974E-07 |
| Normal-VS-Unclassified PRCC |
1.97392999999879E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.51700000003719E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.393700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.660400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.447980E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.95559999999606E-05 |
| KIRP CIMP-VS-Unclassified PRCC |
2.114200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.719700E-02 |
| Normal-vs-N1 |
6.032300E-04 |
| Normal-vs-N2 |
4.753400E-01 |
| N0-vs-N1 |
4.977900E-02 |
| N0-vs-N2 |
6.513400E-01 |
| N1-vs-N2 |
6.605000E-01 |
|
|
